Company-led recall: Ozurdex 700 micrograms intravitreal implant in applicator (dexamethasone)

The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a company-led recall for further batches of Ozurdex 700 micrograms intravitreal implant in applicator (dexamethasone) due to the possibility that a single loose silicone particle of approximately 300 microns in diameter may become detached. 

Further details of the recall, the affected batches, and actions to take are available on the MHRA website.